Pharma Industry deal value drops 69% in October 2024

In October 2024, the pharmaceutical sector disclosed 102 transactions worth $8.9 billion, representing a 69 percent decrease in deal value relative to October 2023. GlobalData reports that this deal activity also did not meet the average from the...

CytoDyn Bags FDA Nod for Phase II Trial of Leronlimab in Colorectal Cancer

CytoDyn Inc., a biotech firm working on leronlimab, a CCR5 inhibitor with possible therapeutic uses, revealed that it has obtained approval from the US FDA to begin its phase II cancer trial. The research will assess how effective leronlimab is...

FDA Clears Journey Medical's Emrosi for Rosacea Treatment

The US FDA has given approval for Journey Medical's Emrosi, a brand name for their 40mg minocycline hydrochloride extended-release capsules, for treating the skin condition rosacea. Created with the help of Dr Reddy's Laboratories, Emrosi...

Venus Remedies Gains PIC/S GMP Approval for Robotic Syringe Facility

Venus Remedies announced that its robotic pre-filled syringe facility at the Baddi unit has been granted approval for good manufacturing practices (GMP) by the National Pharmaceutical Regulatory Agency (NPRA) of Malaysia. Venus Remedies announced...

HuidaGene's First CRISPR RNA-Editing Therapy for nAMD Cleared by US FDA

HuidaGene Therapeutics (HuidaGene), a worldwide biotech company focused on genome medicines in clinical trials, revealed that the US FDA has approved its HG202 investigational new drug (IND) application for neovascular age-related macular...

US FDA Approves Protega Pharma's Roxybond

Protega Pharmaceuticals Inc., a unique specialty pharmaceutical company dedicated to ethical pain control and creating new abuse-resistant products, revealed that the US Food and Drug Administration (FDA) has given the green light for Roxybond...

Chip Assisted Brain Tumor Surgery to Undergo Clinical Trials

A graphene-based brain chip is entering its first clinical trial at Salford Royal Hospital, aiming to revolutionize brain tumor surgeries, according to The Guardian. The device, roughly postage-stamp sized, works by detecting cancer cells through ...

AIIMS Director Proposes Integration of Ayurveda and Modern Allopathy

Dr. Puranik was addressing the second Foundation Day celebration of the Indian Ayurvedic Medical College (IAMC) at the University of Science and Technology Meghalaya (USTM)...

NPPA Issues Memorandum to Companies for Price Reduction on Cancer Drugs

The government has instructed companies to reduce the prices of three anti-cancer drugs in order to pass on the benefits from customs duty exemptions and reductions in GST to consumers. In line with the government’s commitment to ensuring that dru...

Latest Penicillin Plant Boasts Production Capacity of 15,000MT

Lyfius Pharma, a unit of Aurobindo Pharma, on Tuesday said Prime Minister Narendra Modi has inaugurated its Penicillin-G plant at Kakinada, Andhra Pradesh. The facility with an annual production capacity of 15,000 metric tonnes (MT) was virtually ...

© 2024 India Pharma Outlook. All Rights Reserved.